Author:
Posted Time:2025-12-26 00:00
Qingfeng Pharmaceutical Group will participate in BIO Partnering @ JPM Week 2026, which will take place in San Francisco from January 12–15, 2026. Qingfeng’s Vice President, together with the team, will attend the event and hold one-on-one meetings with potential global partners to explore opportunities for international collaboration, including in- and out-licensing of innovative drug programs. If you would like to arrange preliminary discussions in advance, please contact us at BDinfo@kryy.com.cn.
About BIO Partnering @ JPM Week
BIO Partnering @ JPM Week is an annual partnering event hosted by the Biotechnology Innovation Organization (BIO) and held in San Francisco during J.P. Morgan Healthcare (JPM) Week. The program provides a dedicated platform for global biotechnology and pharmaceutical companies, investors, and innovators to engage in strategic discussions, schedule one-on-one meetings, and explore collaboration opportunities. The 2026 partnering event is scheduled for January 12–15.
About Qingfeng Pharma
Qingfeng Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical enterprise group integrating research and development, manufacture and commercialization. Driven by innovative research and development, we have built a collaborative and efficient drug innovation platform in Shanghai, Beijing, Hangzhou, and Ganzhou, focusing on areas include anti-infection, Gastroenterology, CNS, Oncology & Immunology, and has developed a series of attractive innovative pipeline. For the cooperation innovative drugs, Qingfeng is actively seeking partners with open attitudes.
